Insider Trading June 23, 2026 08:57 PM

COMTECH Executive Unloads Shares Amidst Product Rollouts and Earnings Shift

President Daniel Gizinski divests 200 shares as the company navigates fiscal Q3 results and new emergency communications tools.

By Caleb Monroe
Share
Twitter Reddit Facebook LinkedIn
CMTL

Daniel Gizinski, President of the S&S Communications Segment at COMTECH TELECOMMUNICATIONS CORP /DE/ (NASDAQ:CMTL), executed a direct sale of 200 shares of the company’s common stock on June 18, 2026. The transaction occurred at a price of $2.60 per share, resulting in total proceeds of $520. Following this divestment, Gizinski retains a direct holding of 31,040 shares of Comtech’s common stock. The stock is currently trading at $2.39, marking a significant 55% decline year-to-date. Despite the stock's performance, InvestingPro analysis suggests the shares may be undervalued relative to their Fair Value estimate. This insider activity coincides with Comtech's recent fiscal Q3 2026 earnings report, which highlighted a narrower-than-anticipated loss and the introduction of new emergency communication technologies.

COMTECH Executive Unloads Shares Amidst Product Rollouts and Earnings Shift
CMTL
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • COMTECH TELECOMMUNICATIONS CORP /DE/ (NASDAQ:CMTL) President Daniel Gizinski sold 200 shares at $2.60 per share, totaling $520.
  • The company reported fiscal Q3 2026 adjusted earnings of negative $0.47 per share, beating expectations of negative $0.55, though revenue fell short of the $116.19 million forecast.
  • Comtech expanded its emergency communications portfolio with the launch of Allerium Coral and Allerium Mira, while board member Bruce T. Crawford resigned for a new role at AFCEA International.

COMTECH TELECOMMUNICATIONS CORP /DE/ (NASDAQ:CMTL) has seen a notable transaction from one of its senior executives. Daniel Gizinski, who serves as the President of the S&S Communications Segment, sold 200 shares of the company’s common stock on June 18, 2026. The transaction was executed through direct ownership, with each share disposed of at $2.60. This sale generated a total value of $520. As of the latest market data, the stock is trading at $2.39, reflecting a substantial 55% drop in value year-to-date. According to InvestingPro analysis, the current market price may present an undervaluation opportunity when compared to the stock's Fair Value estimate. The platform notes that 11 additional ProTips are available for CMTL, alongside a comprehensive Pro Research Report that details the company’s financial health and future outlook.

Following the sale, Mr. Gizinski’s direct ownership position in Comtech stands at 31,040 shares. This insider activity occurs against a backdrop of recent corporate developments for the telecommunications firm. Comtech recently reported its fiscal Q3 2026 earnings, which revealed a loss that was narrower than market expectations. The company posted adjusted earnings of negative $0.47 per share, outperforming the analyst consensus estimate of negative $0.55. However, revenue performance did not meet projections, with Comtech reporting $106 million in revenue against anticipated figures of $116.19 million.

In parallel with financial results, Comtech announced the resignation of Bruce T. Crawford from its board of directors. Crawford’s departure is attributed to his new appointment as president and CEO of AFCEA International. The company clarified that this transition was not the result of any disagreement with Comtech or its board of directors.

On the product front, Comtech has introduced new tools aimed at enhancing emergency communications. The company launched Allerium Coral, a network-native solution designed to coordinate emergency services information. Additionally, Comtech introduced Allerium Mira, a cloud-native platform built to manage 911 calls within Next Generation 9-1-1 systems. These product advancements underscore Comtech’s strategic focus on improving emergency communications technology.

Key Points

  • COMTECH TELECOMMUNICATIONS CORP /DE/ (NASDAQ:CMTL) President Daniel Gizinski sold 200 shares at $2.60 per share, totaling $520.
  • The company reported fiscal Q3 2026 adjusted earnings of negative $0.47 per share, beating expectations of negative $0.55, though revenue fell short of the $116.19 million forecast.
  • Comtech expanded its emergency communications portfolio with the launch of Allerium Coral and Allerium Mira, while board member Bruce T. Crawford resigned for a new role at AFCEA International.

Sectors Impacted

  • Telecommunications and Emergency Services Technology
  • Cloud-Native Software and Network Infrastructure
  • Insider Trading and Executive Compensation Markets

Risks and Uncertainties

  • COMTECH TELECOMMUNICATIONS CORP /DE/ (NASDAQ:CMTL) stock has declined 55% year-to-date, raising questions about near-term valuation and market sentiment despite undervaluation metrics.
  • Revenue missed projections in fiscal Q3 2026, indicating potential challenges in meeting financial targets or demand forecasting within the telecommunications sector.
  • Executive insider sales, while routine, may be monitored closely by investors given the stock’s significant year-to-date decline and the executive’s retained position of 31,040 shares.

Risks

  • COMTECH TELECOMMUNICATIONS CORP /DE/ (NASDAQ:CMTL) stock has declined 55% year-to-date, raising questions about near-term valuation and market sentiment despite undervaluation metrics.
  • Revenue missed projections in fiscal Q3 2026, indicating potential challenges in meeting financial targets or demand forecasting within the telecommunications sector.
  • Executive insider sales, while routine, may be monitored closely by investors given the stock’s significant year-to-date decline and the executive’s retained position of 31,040 shares.

More from Insider Trading

ConnectM CFO Choudhury Accumulates Shares Ahead of Sharp Price Rally Jun 23, 2026 ConnectM CEO Increases Holdings Amid Market Volatility Jun 23, 2026 Spyre Therapeutics Director-Affiliated Fund Liquidates Nearly $400 Million Stake Jun 23, 2026 Spyre Therapeutics Director Henderson Offloads $2 Million in Equity Under Pre-Arranged Plan Jun 23, 2026 Crescent Biopharma CFO Sells Shares to Cover Tax Obligations Amid Clinical Developments Jun 23, 2026